Wide Ranks

LSBPW

0.0400

Top Statistics
Market Cap 0.0000 Forward PE 0.0000 Revenue Growth 27.70 %
Current Ratio 1.13 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -75.59 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins -75.59 % Operating Margins -68.83 %
Balance Sheet
Total Cash 246 M Total Cash Per Share 12.91 Total Debt 424 M
Total Debt To Equity 72.53 Current Ratio 1.13 Book Value Per Share 30.76
All Measures
Message Board Id finmb_207278456 Return On Equity -0.6599 City Beijing
Uuid 3a8ab42d-fa50-3c24-9153-75b68171c5f1 Previous Close 0.0400 Book Value 30.76
Beta 0.7400 Total Debt 424 M Volume 1956
Price To Book 0.0013 Fifty Two Week Low 0.0400 Total Cash Per Share 12.91
Total Revenue 573 M Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins -68.83 % Net Income To Common -433464864 Ask 0.0597
Trailing Peg Ratio None Total Cash 246 M Revenue Per Share 53.63
Ebitda Margins -55.09 % Trailing PE 0.0000 Regular Market Previous Close 0.0400
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Open 0.0400
Free Cashflow -216485936 Dividend Yield 0.00 % Return On Assets -0.1385
Time Zone Short Name EST Day Low 0.0400 Address1 Building No. 2
Target High Price 0.0000 Price Hint 4 Website https://www.ysbiopharm.com
Forward Eps 0.0000 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 86.40 % Is_sp_500 False Regular Market Day High 0.0400
Profit Margins -75.59 % Debt To Equity 72.53 Fifty Two Week High 0.0400
Day High 0.0400 Regular Market Open 0.0400 Industry Key biotechnology
Bid 0.0729 Earnings Growth 0.00 % Revenue Growth 27.70 %
Operating Cashflow -295229600 Currency USD Time Zone Full Name America/New_York
Is_nasdaq_100 False Market Cap 0.0000 Zip 102629
Quote Type EQUITY Industry Biotechnology Long Name LakeShore Biopharma Co., Ltd
Regular Market Day Low 0.0400 Current Price 0.0400 Address2 38 Yongda Road Daxing Biomedical Industry Park Daxing District
Financial Currency CNY Current Ratio 1.13 Gross Margins 67.33 %
Industry Disp Biotechnology Country China Float Shares 3 M
Forward PE 0.0000 Regular Market Volume 1956 Ebitda -315903072
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
LakeShore Biopharma Co.

, Ltd, a biopharmaceutical company, engages in the discovering, developing, manufacturing, commercializing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer.

The company's product pipeline includes YSJA, a conventional rabies vaccine which is in marketed stage; PIKA, a rabies vaccine which are in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic that is in phase I trials for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine that is in phase I trials; PIKA YS-HBV-002, an immune-therapy vaccine which is in IND preclinical trials for the  treatment of chronic HBV infection; and  PIKA YS-ON-001 and PIKA Influenza Vaccine which are in preclinical trials.

It operates in China, Singapore, the United States, and the Philippines.

The company was formerly known as YS Biopharma Co.

, Ltd.

and changed its name to LakeShore Biopharma Co.

, Ltd in May 2024.

The company was founded in 2002 and is based in Beijing, China.